| Issue |
BIO Web Conf.
Volume 41, 2021
The 4th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2021)
|
|
|---|---|---|
| Article Number | 07004 | |
| Number of page(s) | 6 | |
| Section | Drug Development and Nutraceutical | |
| DOI | https://doi.org/10.1051/bioconf/20214107004 | |
| Published online | 22 December 2021 | |
Potential of Nanoparticles Chitosan for Delivery pcDNA3.1-tat
1
Department of Reproduction and Obstetrics, Faculty of Veterinary Medicine, University Gadjah Mada, Yogyakarta, 55281, Indonesia
2
Department of Pathology, Faculty of Veterinary Medicine, University Gadjah Mada, Yogyakarta, 55281, Indonesia
3
Biomedical Field, Nursing Study Program, STIKES Yarsi Mataram, West Nusa Tenggara, 83361, Indonesia
* Corresponding author: uma_vet@ugm.ac.id
The development of Jembrana disease vaccine is importance to prevent the loss of Bali cattle industry in Indonesia. This study aims to prepare a Jembrana DNA vaccine. The data Tat protein sequences gained from NCBI and the consensus process has been finished by the MultAlign program, and then Cloning of the pcDNA3.1-tat has been successfully performed on E. coli DH5α and confirmed by PCR, restriction analysis and sequencing. The propagated plasmids were prepared as DNA-chitosan complex and physiochemical characterized using Particle Size Analyzer. Complex with a 1:2 (wt/wt) ratio of DNA and chitosan have a mean diameter of 268.5 nm and zeta potential +25.1 mV and the value of Cytotoxicity Assay 80-90% as compared to the untreated cells that used as negative control, so it can be concluded that nanoparticles chitosan has good potential as a carrier agent for pcDNA3.1-tat.
Key words: A consensus sequences / Chitosan nanoparticles / JDV Tat protein / Jembrana disease virus / Delivery System
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.